OPKO Health (NASDAQ:OPK) Rating Reiterated by Barrington Research
OPKO Health (NASDAQ:OPK – Get Free Report)‘s stock had its “outperform” rating restated by Barrington Research in a report issued on Friday, Benzinga reports. They currently have a $2.25 price target on the biotechnology company’s stock. Barrington Research’s target price indicates a potential upside of 52.03% from the company’s previous close. Several other equities analysts […]
Barrington Research Reiterates Outperform Rating for Lincoln Educational Services (NASDAQ:LINC)
Lincoln Educational Services (NASDAQ:LINC – Get Free Report)‘s stock had its “outperform” rating reissued by equities research analysts at Barrington Research in a report released on Friday, Benzinga reports. They currently have a $16.00 price target on the stock. Barrington Research’s target price suggests a potential upside of 28.31% from the company’s previous close. A […]
Barrington Research Reiterates Outperform Rating for Henry Schein (NASDAQ:HSIC)
Henry Schein (NASDAQ:HSIC – Get Free Report)‘s stock had its “outperform” rating reissued by research analysts at Barrington Research in a research note issued to investors on Friday, Benzinga reports. They presently have a $82.00 price target on the stock. Barrington Research’s target price indicates a potential upside of 15.25% from the company’s previous close. […]
Playtika (NASDAQ:PLTK) Rating Reiterated by Wedbush
Playtika (NASDAQ:PLTK – Get Free Report)‘s stock had its “outperform” rating reaffirmed by Wedbush in a research report issued to clients and investors on Thursday, Benzinga reports. They presently have a $11.50 target price on the stock. Wedbush’s price objective indicates a potential upside of 47.06% from the stock’s previous close. Several other equities research […]
last updated on 22 Sep 10:11